Search - tctmd.com

Displaying 641 - 660 of 1588

Sort: Relevancy | Date

Presentation TCT 2019

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Presenter: Hirotoshi Watanabe

September 28, 2019

Presentation TCT 2019

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

Presenter: Amit Vora

September 28, 2019

Presentation TCT 2019

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Presenter: Duk-Woo Park

September 28, 2019

Presentation TCT 2019

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Presenter: Bruno Scheller

September 28, 2019

Presentation TCT 2019

Critical Analysis of De Novo and ISR Clinical Trial Data

Presenter: Fernando Alfonso

September 28, 2019

Presentation TCT 2019

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

Presenter: Matthew Price

September 27, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

FFR-CT State of the Art Clinical Study Evidence and Ongoing/Planned Trials

Presenter: Manesh Patel

September 27, 2019

Presentation TCT 2019

Physiology and Coronary Imaging: When to Use Either, Both, or Neither?

Presenter: Andreas Baumbach

September 27, 2019

Presentation TCT 2019

Resting Indices vs. Hyperemic Evaluation of Physiology in ACS: What Did We Learn From DEFINE-FLAIR and Swedeheart?

Presenter: Christopher Cook

September 27, 2019

Presentation TCT 2019

Post-PCI Physiology: Insights From DEFINE PCI and Other Studies

Presenter: Allen Jeremias

September 27, 2019

Presentation TCT 2019

TIRATROP: A Double-Blind Randomized Trial of Ticagrelor in Patients Undergoing High-Speed Rotational Atherectomy

Presenter: Thibault Lhermusier

September 27, 2019

Presentation TCT 2019

The Case for Functional (Not Anatomic) Complete Revascularization: Preview of FAME 3

Presenter: William Fearon

September 27, 2019

Presentation TCT 2019

While Awaiting More Clinical Trial Data: Real-World Approaches to Cardiogenic Shock and Hemodynamic Support

Presenter: Alexander Truesdell

September 27, 2019

Presentation TCT 2019

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

Presenter: Otavio Berwanger

September 27, 2019

Presentation TCT 2019

Physiological Guidance in Multivessel Disease PCI: Lessons Learned From SYNTAX II 3-Year Follow

Presenter: Javier Escaned

September 27, 2019

Presentation TCT 2019

Long-Term Outcomes With Physiology Guidance: Increased Risk for MI Among Patients Treated Medically?

Presenter: Nils Johnson

September 27, 2019

Presentation TCT 2019

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

Presenter: Matthias Götberg

September 27, 2019

Presentation TCT 2019

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Presenter: Gregg Stone

September 27, 2019

Advertisement

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Critical Analysis of De Novo and ISR Clinical Trial Data

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Portico Noninferior to Commercial TAVR Valves in IDE Study

FFR-CT State of the Art Clinical Study Evidence and Ongoing/Planned Trials

Physiology and Coronary Imaging: When to Use Either, Both, or Neither?

Resting Indices vs. Hyperemic Evaluation of Physiology in ACS: What Did We Learn From DEFINE-FLAIR and Swedeheart?

Post-PCI Physiology: Insights From DEFINE PCI and Other Studies

TIRATROP: A Double-Blind Randomized Trial of Ticagrelor in Patients Undergoing High-Speed Rotational Atherectomy

The Case for Functional (Not Anatomic) Complete Revascularization: Preview of FAME 3

While Awaiting More Clinical Trial Data: Real-World Approaches to Cardiogenic Shock and Hemodynamic Support

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

Physiological Guidance in Multivessel Disease PCI: Lessons Learned From SYNTAX II 3-Year Follow

Long-Term Outcomes With Physiology Guidance: Increased Risk for MI Among Patients Treated Medically?

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content